Systematic review: Prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography

Nuclear Medicine Communications

Volumn 30, Issue 9, 2009, Pages 742-748

  Shie, Philip ^a   Cardarelli, Roberto ^b   Sprawls, Kelly ^b   Fulda, Kimberly G ^b   Taur, Alan ^a  

^a KAISER PERMANENTE   (United States)

^b University of North Texas Health Science Center   (United States)

Author keywords

Fluorodeoxyglucose; Incidental findings; Positron emission tomography; Thyroid carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INCIDENCE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; SYSTEMATIC REVIEW; THYROID DISEASE; THYROID NODULE;

FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; POSITRON-EMISSION TOMOGRAPHY; THYROID NODULE;

EID: 68249136839     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832ee09d     Document Type: Article

References (49)

1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69: 537-540.
2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7:481-493. (Pubitemid 8235965)
3. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181:683-687.
4. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154:1838-1840.
5. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93:359-362.
6. Tomimori E, Pedrinola F, Cavaliere H, Knobel M, Medeiros-Neto G. Prevalence of incidental thyroid disease in a relatively low iodine intake area. Thyroid 1995; 5:273-276.
7. Bruneton JN, Balu-Maestro C, Marcy PY, Melia P, Mourou MY. Very high frequency (13MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994; 13:87-90. (Pubitemid 24047074)
8. Mitchell J, Parangi S. The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR 2005; 26:37-46. Review. (Pubitemid 40261291)
9. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126:226-231. (Pubitemid 27061578)
10. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26:189-218. (Pubitemid 27123901)
11. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 2005; 236:271-275.
12. Erdi YE, Nehmeh SA, Mulnix T, Humm JL, Watson CC. PET performance measurements for an LSO-based combined PET/CT scanner using the National Electrical Manufacturers Association NU 2-2001 standard. J Nucl Med 2004; 45:813-821. (Pubitemid 47618561)
13. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, Horiuchi M. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207:775-778. (Pubitemid 28279912)
14. Schmid DT, Kneifel S, Stoeckli SJ, Padberg BC, Merrill G, Goerres GW. Increased 18F-FDG uptake mimicking thyroid cancer in patient with Hashimoto's thyroiditis. Eur Radiol 2003; 13:2119-2121. (Pubitemid 37080746)
15. Boerner AR, Voth E, Theissen P,Wienhard K,Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluorodeoxyglucose positron emission tomography. Thyroid 1998; 8:765-772. (Pubitemid 28535685)
16. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in autonomous goiter measured by F-18-fluoro- deoxyglucose positron emission tomography. Exp Clin Endocrinol Diabetes 2000; 108:191-196.
17. 18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Nucl Med Commun 2003; 24:1225-1230.
18. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 2007; 14:239-247. [Epub 6 October 2006]
19. Macapinlac HA. Clinical usefulness of FDG-PET in differentiated thyroid cancer. J Nucl Med 2001; 42:77-78. (Pubitemid 32104781)
20. McDougall IR, Davidson J, Segall GM. Positron emission tomography of the thyroid, with an emphasis on thyroid cancer. Nucl Med Commun 2001; 22:485-492. Review. (Pubitemid 32458175)
21. Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG-PET: histopathologic comparison. Radiology 2004; 230:417-422. [Epub 29 December 2003]
22. 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007; 28: 373-381.
23. 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005; 25:1421-1426.
24. 18F-FDG-PET/CT: clinical significance and improved characterization. J Nucl Med 2006; 47:609-615.
25. Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, Li BD. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 2006; 72:272-275.
26. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130:941-946. (Pubitemid 34014558)
27. Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006; 33:541-552. [Epub 2006 Feb 21]
28. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46:752-757. (Pubitemid 43750749)
29. 18F- fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88:4100-4104.
30. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005; 115:1074-1078. (Pubitemid 40777005)
31. King DL, Stack BC Jr, Spring PM, Walker R, Bodenner DL. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 2007; 137:400-404. (Pubitemid 47320854)
32. Kurata S, Ishibashi M, Hiromatsu Y, Kaida H, Miyake I, Uchida M, Hayabuchi N. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis. Ann Nucl Med 2007; 21:325-330. Epub 2007 Aug 27. (Pubitemid 47283256)
33. Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005; 23:6846-6853. (Pubitemid 46264014)
34. Little SG, Rice TW, Bybel B, Mason DP, Murthy SC, Falk GW, et al. Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg 2007; 31:791-796. [Epub 2 March 2007]
35. Nam SY, Roh JL, Kim JS, Mason DP, Murthy SC, Falk GW, et al. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf) 2007; 67:135-139. [Epub 27 April 2007]
36. Nishiyama Y, Yamamoto Y, Yokoe K, Miyabe K, Ogawa T, Toyama Y, et al. FDG-PET as a procedure for detecting simultaneous tumours in head and neck cancer patients. Nucl Med Commun 2005; 26:239-244. (Pubitemid 40411047)
37. 18F- FDGPET in staging of patients with esophageal cancer. J Nucl Med 2005; 46:1321-1325.
38. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 1993; 114:728-734; discussion 734-735.
39. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989; 106:980-986.
40. Yousem DM, Scheff AM. Thyroid and parathyroid gland pathology: role of imaging. Otolaryngol Clin North Am 1995; 28:621-649.
41. Sasaki M, Ichiya Y, Kuwabara Y, Akashi Y, Yoshida T, Fukumura T, Masuda K. An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. Nucl Med Commun 1997; 18:957-963. (Pubitemid 27497511)
42. 18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000; 85:1107-1113.
43. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, et al. Fluorine-18-fluorodoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003; 133:294-299. (Pubitemid 36390792)
44. Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol 2002; 178:687-691.
45. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med 2004; 23:1455-1464.
46. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941-1946. (Pubitemid 34521470)
47. Shetty SK, Maher MM, Hahn PF. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. Am J Roentgenol 2006; 187:1349-1356.
48. Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 2008; 32:1247-1252.
49. Faquin WC. The thyroid gland: recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med 2008; 132:622-632.